A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women

Hormone and Metabolic Research

Volumn 47, Issue 7, 2014, Pages 504-508

  Mesri Alamdari, N ^a   Mahdavi, R ^a   Roshanravan, N ^a   Lotfi Yaghin, N ^a   Ostadrahimi, A R ^a   Faramarzi, E ^b  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

inflammation; low calorie diet; melatonin; obesity; oxidative stress

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; MALONALDEHYDE; MELATONIN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BEDTIME DOSAGE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HIP CIRCUMFERENCE; HUMAN; INFLAMMATION; LIPID PEROXIDATION; LOW CALORY DIET; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TOTAL ANTIOXIDANT CAPACITY; WAIST CIRCUMFERENCE; BLOOD; DRUG EFFECTS; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; TREATMENT OUTCOME;

ADULT; C-REACTIVE PROTEIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; MALONDIALDEHYDE; MELATONIN; OBESITY; OXIDATIVE STRESS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930084393     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1384587     Document Type: Article

References (38)

1. World health statistics [Internet] WHO. 2012; 110 111 Available from http://www.who.int
2. Lumeng C. N., Saltiel A. R. Inflammatory links between obesity and metabolic disease. J Clin Invest: 2011; 121 2111 2118
3. Mathieu P., Poirier P., Pibarot P., Lemieux I., Després J. P. Visceral obesity the link among inflammation, hypertension, and cardiovascular disease. Hypertension: 2009; 53 577 584
4. McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology: 2005; 19 871 881
5. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol: 2005; 115 911 919
6. Fernández-Sánchez A., Madrigal-Santillán E., Bautista M., Esquivel-Soto J., Morales-González Á, Esquivel-Chirino C., Durante-Montiel I., Sánchez-Rivera G., Valadez-Vega C., Morales-González J. A. Inflammation, oxidative stress, and obesity. Int J Mol Sci: 2011; 12 3117 3132
7. Beltowski J., Wojcicka G., Gorny D., Marciniak A. The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol: 2000; 51 883 896
8. Wadden T. A., Butryn M. L., Wilson C. Lifestyle modification for the management of obesity. Gastroenterology: 2007; 132 2226 2238
9. Pillitteri J. L., Shiffman S., Rohay J. M., Harkins A. M., Burton S. L., Wadden T. A. Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity: 2008; 16 790 796
10. Jiménez-Aranda A., Fernández-Vázquez G., Campos D., Tassi M., Velasco-Perez L., Tan D. X., Reiter R. J., Agil A. Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J Pineal Res: 2013; 55 416 423
11. Tan D. X., Manchester L., Fuentes-Broto L., Paredes S., Reiter R. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev: 2011; 12 167 188
12. Cipolla-Neto J., Amaral F., Afeche S., Tan D., Reiter R. Melatonin, energy metabolism, and obesity. J Pineal Res: 2014; 56 371 381
13. Hardeland R., Madrid J. A., Tan D. X., Reiter R. J. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res: 2012; 52 139 166
14. Cardinali D. P., Srinivasan V., Brzezinski A., Brown G. M. Melatonin and its analogs in insomnia and depression. J Pineal Res: 2012; 52 365 375
15. Galano A., Tan D. X., Reiter R. J. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res: 2013; 54 245 257
16. Calvo J. R., González-Yanes C., Maldonado M. The role of melatonin in the cells of the innate immunity: a review. J Pineal Res: 2013; 55 103 120
17. Hussein M. R., Ahmed O. G., Hassan A. F., Ahmed M. A. Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal model. Int J Exp Pathol: 2006; 88 19 29
18. Wolden-Hanson T., Mitton D., McCants R., Yellon S., Wilkinson C., Matsumoto A., Rasmussen D. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology: 2000; 141 487 497
19. Prunet-Marcassus B., Desbazeille M., Bros A., Louche K., Delagrange P., Renard P., Casteilla L., Pénicaud L. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology: 2003; 144 5347 5352
20. Puchalski S. S., Green J. N., Rasmussen D. D. Melatonin effect on rat body weight regulation in response to high-fat diet at middle age. Endocrine: 2003; 21 163 167
21. Nduhirabandi F., Du Toit E. F., Blackhurst D., Marais D., Lochner A. Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res: 2011; 50 171 182
22. Mauriz J. L., Collado P. S., Veneroso C., Reiter R. J., González-Gallego J. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res: 2013; 54 1 14
23. Barlow-Walden L., Reiter R., Abe M., Pablos M., Menendez-Pelaez A., Chen L-D, Poeggeler B. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int: 1995; 26 497 502
24. Rodriguez C., Mayo J. C., Sainz R. M., Antolin I., Herrera F., Martin V., Reiter R. J. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res: 2004; 36 1 9
25. Tomás-Zapico C., Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res: 2005; 39 99 104
26. Cuzzocrea S., Reiter R. J. Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem: 2002; 2 153 165
27. Radogna F., Diederich M., Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmaco: 2010; 80 1844 1852
28. Reiter R. J., Tan D., Burkhardt S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev: 2002; 123 1007 1019
29. Rasmussen D. D., Boldt B. M., Wilkinson C., Yellon S. M., Matsumoto A. M. Daily melatonin administration at middle age suppresses male rate visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology: 1999; 140 1009 1012
30. She M., Deng X., Guo Z., Laudon M., Hu Z., Liao D., Hu X., Luo Y., Shen Q., Su Z. NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats. Pharmacol Res: 2009; 59 248 253
31. Kedziora-Kornatowska K., Szewczyk-Golec K., Kozakiewicz M., Pawluk H., Czuczejko J., Kornatowski T., Bartosz G., Kedziora J. Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J Pineal Res: 2009; 46 333 337
32. Koziróg M., Poliwczak A. R., Duchnowicz P., Koter-Michalak M., Sikora J., Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res: 2011; 50 261 266
33. Reiter R. J., Paredes S. D., Manchester L. C., Tan D-X. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol: 2009; 44 175 200
34. Kedziora-Kornatowska K., Szewczyk-Golec K., Czuczejko J., Pawluk H., Van Marke de Lumen K., Kozakiewicz M., Bartosz G., Kedziora J. Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. J Pineal Res: 2008; 45 312 317
35. Tan D-X, Chen L., Poeggeler B., Manchester L., Reiter R. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J: 1993; 1 57 60
36. Jung K. H., Hong S. W., Zheng H. M., Lee H. S., Lee H., Lee D. H., Lee S. Y., Hong S. S. Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats. J Pineal Res: 2010; 48 239 250
37. Veneroso C., Tuñón M. J., González-Gallego J., Collado P. S. Melatonin reduces cardiac inflammatory injury induced by acute exercise. J Pineal Res: 2009; 47 184 191
38. Cichoz-Lach H., Celinski K., Konturek P., Konturek S., Slomka M. The effects of l -tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis. J Physiol Pharmacol: 2010; 61 577 580